CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The UNIBIO project focuses on the TK210 ELISA test, a blood-based biomarker for cancer diagnosis and treatment monitoring. This test aims to provide a cost-effective and minimally invasive method for assessing cancer progression and therapy response.
The UNIBIO project is a feasibility study for TK210 ELISA – a serum and plasma biomarker for cancer diagnosis and treatment response.
Leveraging on the knowledge that cancer cells undergoing rapid growth produce and release into the blood abnormal amounts of protein called thymidine kinase (TK), AroCell has pre-validated a biomarker that quantifies the amount of TK protein directly in the serum in a blood sample.
Current cell growth-related biomarkers are measured from tumour tissue, which limi…
AROCELL AB (PUBL)
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
